ROP:SWX
Roche Holding AG Genussscheine
CHF 353.90
arrow_downward
-1.78%(-6.40) 1D
Sep 28, 2:41:30 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHF 364.00
High
CHF 365.50
Low
CHF 350.40
Mkt. cap
322.34B
Avg. vol.
944.23K
Volume
356.28K
Dividend
2.77%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.09
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHF 364.00
High
CHF 365.50
Low
CHF 350.40
Mkt. cap
322.34B
Avg. vol.
944.23K
Volume
356.28K
Dividend
2.77%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
23.09
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
WSJ
·
15 minutes ago
Roche Halts Development of Obesity Drug Candidate
BigGo Finance
·
58 minutes ago
Roche Pushes Toward Fully Autonomous AI Labs in Drug Research
Yahoo Finance
·
58 minutes ago
Roche Plans Autonomous AI-Driven Laboratories for Drug Development
Investing.com
·
1 hour ago
Roche plans autonomous AI labs to speed up drug development
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com